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A drastic inhibition of protein synthesis occurs in HeLa cells treated with human lymphoblastoid 
interferon and infected with poliovirus. At the time when this inhibition has been established no 
degradation of 32P-labelled ribosomal RNA can be detected. Isolation of the mRNAs from poliovirus- 
infected cells plus or minus interferon treatment, followed by translation in a reticulocyte lysate indicates 
that cellular mRNAs remain active. These results suggest hat gross degradation of cellular RNA does not 
occur in interferon-treated poliovirus-infected HeLa cells and that a non-specific nuclease induced by 
2’-S A is not responsible for the inhibition of protein synthesis observed. 
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1. INTRODUCTION 
Interferons are inducible proteins synthesised by 
mammalian cells in response to an array of dif- 
ferent stimuli [l]. They interact with homologous 
cells and produce in them different biological ef- 
fects [l-3]. Amongst these, the antiviral and anti- 
proliferative activities of interferon have been 
most widely studied. 
The interaction of interferon with a target cell 
induces the synthesis of a number of proteins. 
Some of these, like the 2’-5’ A synthetase [4-61, 
the protein kinase [4-61 and the major histocom- 
patibility antigens [7,11], have been identified, but 
there are likely to be others [ 11,141. The synthesis 
of these new proteins is required to establish the 
so-called ‘antiviral state’ and virus growth in such 
cells is inhibited. The step in virus development 
that is inhibited in IFN-treated cells is different for 
different virus species 16,151. For the picorna- 
viruses, there is evidence that the antiviral activity 
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Shut-off 2 ‘-5 ‘A Synthetase RNA degradation 
involves an inhibition of viral protein synthesis 
[16] and two different mechanisms to explain the 
i~ibition have been proposed 15,171. One involves 
an increase in a protein kinase activity that is acti- 
vated by double-stranded (ds) RNA. The kinase 
phosphorylates an initiation factor, most probably 
the small subunit of eIF2, and results in the inhibi- 
tion of its activity. As yet no evidence exists that 
the eIF2 becomes phosphorylated in virus-infected 
cells pretreated with interferon 1181. The other 
mechanism proposed to explain the inhibition of 
protein synthesis, involves an enzyme known as the 
2’-5’-oligo(A) synthetase. This enzyme is also acti- 
vated by dsRNA and catalyses the synthesis of a 
series of oligonucleotides known collectively as 
2’-S-oligo(A) [4,6]. These oligonucleotides, in 
turn, trigger the activation of an endogenous nu- 
clease activity that non-specifically degrades RNA 
and leads to the inhibition of protein synthesis. 
Though the 2’-5’-oligo(A) has been detected in 
interferon-treated virus-infected cells [ 171, as yet 
there is very little evidence to indicate whether 
either mechanism operates in intact cells, and if so, 
which predominates. 
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In contrast to the paucity of evidence in vivo, 
there is now overwhelming evidence obtained from 
cell-free systems that the 2’-5’ A system can inhibit 
the translation of viral and cellular mRNAs in 
vitro [19]. Moreover, translation is inhibited in 
cells permeabilized to 2’-5’-oligo(A), perhaps sug- 
gesting that this compound can activate a nuclease 
in the cytosol of the intact cell [20]. Evidence from 
EMC-infected cells indicates that 2’-5’-oligo(A) is 
synthesized in amounts considered sufficient to ac- 
tivate the nuclease [21]. However, it has been 
found [22] that he stability of early mRNA coding 
for SV40 T-antigen is unchanged in BSC-1 cells 
following treatment with interferon and the 
mRNA remains active in cell-free systems. Fur- 
thermore, mRNA from L cells treated with mouse 
interferon and infected with mengovirus is not 
degraded and can be translated in vivo [23]. These 
results argue against a non-specific nuclease as the 
basis of the antiviral effect. 
2. MATERIALS AND METHODS 
2.1. Cells and virus 
HeLa cells were grown and propagated in 
Dulbecco’s modified Eagle’s medium (E4) supple- 
mented with 10% calf serum. Poliovirus type I was 
grown on HeLa cells in Dulbecco’s modified 
Eagle’s medium supplemented with 1% calf serum. 
The fraction obtained after removal of cell debris 
by low-speed centrifugation was used as source of 
virus. 
2.2. Interferon 
Human lymphoblastoid interferon (HuIFN-cz 
(Ly); 1.6 x lo6 IU/mg protein) was a generous gift 
of Drs Finter, Fantes and Johnston, Wellcome 
Research Labs. (Beckenham). 
2.3. Labelling and analysis of protein in vivo 
Cells were grown in 30-mm diam. dishes and 
pulsed with 0.5 ml E4 medium without methionine 
containing 1% calf serum and 5.4&i [35S]methio- 
nine (1000 Ci. mmol-I). At the end of the labelling 
period the medium was removed. Cell monolayers 
were washed with phosphate buffer solution and 
dissolved in 200~10.02 N NaOH plus 1% SDS and 
200~1 of buffer [62.5 mM Tris (pH 6.8), 2% SDS, 
0.1 M dithiotreitol, 17% glycerol and 0.024% 
Bromophenol blue as indicator]. Samples were 
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sonicated to reduce viscosity and heated at 90°C 
for 5 min; 10~1 were precipitated with 10% tri- 
chloroacetic acid and filtered through GF/C filters. 
The radioactivity retained in the filters was esti- 
mated in an Intertechnique spectrometer using a 
toluene-PPO-POPOP cocktail. Other 10~1 sam- 
ples were applied to a 15% polyacrylamide gel and 
run overnight at 30V. Fluorography of the gels 
was done with 2,5-diphenyloxazole/dimethylsul- 
foxide (20%) w/w). The dried gels were exposed to 
X-ray films. 
2.4. Analysis of 13’P]RNA 
Cells were grown in lOO-mm diam. dishes. When 
they reached confluence the medium was removed 
and the monolayers were washed with E4 medium 
without phosphate for 15 min. Then 6ml of 
E4 medium containing 0.1 mM phosphate and 
250&i/ml carrier-free [32P]phosphate and 2% 
fetal calf serum dialyzed against Eagles saline with- 
out phosphate, were added; 6 h later 200 IU/ml 
HuIFN-cu (Ly) was added to the corresponding 
dishes, and 18 h after this the medium was re- 
moved and the cells were infected with poliovirus 
(20 PFU/cell). After 1 h at 37°C the cells were 
placed in E4 medium containing 2% calf serum 
and 4 h later the RNA was extracted. For this pur- 
pose the medium was removed and cell monolayers 
were washed 3-times with phosphate saline salu- 
tion, scraped off in E4 medium using a rubber 
policeman, washed 3-times and resuspended in 
2 ml 10mM NaCl, 1.5 mM MgC12,0.1 mM EDTA, 
10mM Tris-HCl (pH 7.4), 5Opg dextran sul- 
fate/ml and 220~1 10% NP40. Nuclei were re- 
moved by centrifugation at 900 x g for 5 min at 
2°C. The supernatant was made of 2 M LiCl and 
1% SDS and left overnight at -20°C. RNAs were 
collected by centrifugation at 8000 x g for 30 min 
at 2”C, resuspended in distilled water and stored at 
-80°C; 20 000 cpm of each sample were applied to 
a 1.5% agarose gel and run for 2.5 h at 25 mA. The 
gel was stained with ethidium bromide (lo/g/ml) 
for 10min and then dried and exposed to X-ray 
film. 
2.5. Purification and cell-free translation 
of mRNAs 
The medium was removed 5 h after poliovirus 
infection and the cell monolayers were washed 
with phosphate saline solution and chilled Tris- 
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saline; 2 ml/dish of Tris-saline were added and 
cells scraped off with a rubber policeman. 
Cells were collected into siliconised tubes by cen- 
trifugation at 9000 x g for 5 min at O”C, washed 
3-times with Tris-saline and resuspended in 10 vol. 
NDS buffer [20 mM Tris (pH 7.5), 100 mM NaCl, 
1 mM EDTA, pH 7.5, 1% naththalene-l,5-disul- 
phonic acid-disodium salt] and l/lOth vol. of 
10% NP40. Nuclei were pelleted by centrifugation 
at 10000 x g for 5 min at 0°C. The supernatant was 
collected and 1/3Oth vol. 15% SDS, 1130th vol. 
3 mg/ml potassium polyvinyl sulphate and 1 vol. 
phenol : chloroform : isoamyl alcohol (50 : 50 : 1, by 
vol.) were added. The phenol extraction was re- 
peated 3-times at room temperature and was fol- 
lowed by extraction with chloroform : isoamyl 
alcohol (50: 1, v/v). The final aqueous phase was 
made 0.1 M NaCl and left overnight at -20°C with 
2.5 vol. ethanol. The RNAs were collected by cen- 
trifugation at 10000 x g for 30 min at O”C, resus- 
pended in distilled water and reprecipitated 3-times 
to remove phenol and finally resuspended in 0.7 M 
NaCl, 10mM EDTA (pH 7.5), 25% formamide 
and 50 mM Tris (pH 7.5). The poly(A)+ fractions 
were then removed from the total cellular RNAs by 
affinity chromatography through 25021 poly(U)- 
Sepharose 2B columns. The retained RNA was 
eluted with a buffer containing 90% formamide, 
10mM EDTA (pH 7.5), 0.2% SDS and 10mM 
Tris (pH 7.5) and precipitated overnight with 
0.1 M NaCl and 2.5 vol. -20°C ethanol at this 
temperature. mRNAs were collected and washed 
as before and finally their purities checked using a 
190-450 nm scan. 
The in vitro assay for protein synthesis was car- 
ried out in micrococcal nuclease-treated reticulo- 
cyte lysates prepared as in [29]. Each tube con- 
tained (in 30~1): 20~1 reticulocyte lysate, 165gM of 
each of the unlabelled L-amino acids minus methio- 
nine, 30,&i [35S]methionine(1000Ci/mmol), 5 mM 
2-aminopurine and the indicated quantity of 
mRNA of each origin. After 90min incubation at 
34’C, 2,ul of each sample were analyzed by poly- 
acrylamide gel electrophoresis followed by fluoro- 
graphy and autoradiography as above. Other sam- 
ples (2~1) were incubated at 34°C for 15 min with 
20 vol. Hz02 and precipitated with 10% trichloro- 
acetic acid. The radioactivity incorporated into 
proteins was estimated after filtration on nibro- 
cellulose filters. 
3. RESULTS AND DISCUSSION 
We have studied HeLa cells infected with polio- 
virus and treated with human lymphoblastoid in- 
terferon and asked two questions: 
(i) Is there inhibition of protein synthesis in polio- 
virus-infected HeLa cells when they are pre- 
treated with interferon? 
(ii) Is the 2’-5’A activated nuclease involved in 
this inhibition? 
To answer the first question HeLa cells were 
treated with a high dose of interferon (50IU/ml) 
sufficient to block the production of infectious 
virus by almost 99%, and then infected with polio- 
virus at a high multiplicity (20 PFU/cell). Protein 
synthesis was followed throughout infection by 
estimating the amount of [3sS]methionine incor- 
porated into trichloroacetic acid precipitable ma- 
terial and by analysis of the proteins synthesized 
on polyacrylamide gels. Fig.1 shows that a drastic 
inhibition of translation takes place in poliovirus- 
infected HeLa cells, and this is even more marked 
when the cells are pre-treated with the HuIFN-(Y 
(Ly). Analysis of the proteins synthesized indicated 
that interferon treatment blocks the appearance of 
detectable amounts of poliovirus proteins. 
To know whether the shut-off of host protein 
synthesis that occurs in IFN-treated cells is mediated 
by the non-specific degradation of RNA, we ana- 
lyzed the RNAs from poliovirus-infected HeLa 
cells, plus or minus IFN-treatment. In the first ex- 
periment he cellular RNAs were labelled overnight 
with [32P]phosphate. The label was removed and 
the cells were infected with poliovirus. The RNA 
was extracted 4 h after infection at the time when 
shut-off of protein synthesis was maximal. The ex- 
tracted RNA was analyzed by agarose gels, stained 
with ethidium bromide and autoradiographed. No 
degradation of ribosomal RNA was apparent 
(fig.2). Contrary to the results using cell-free sys- 
tems, where the 2’-5’-oligo(A)-activated nuclease 
causes extensive non-specific degradation of RNA 
[4-61, this experiment indicates that no gross de- 
gradation of cellular RNAs occurs in intact cells. 
The experiment in fig.2 cannot exclude the pos- 
sibility that cellular mRNAs are specifically modi- 
fied or degraded in the interferon-treated, infected 
cells, and rendered inactive in protein synthesis. To 
test this possibility the mRNA was extracted from 
untreated cells and cells treated with interferon 5 h 
89 
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Fig.1. Effect of human lymphoblastoid interferon in 
poliovirus-infected HeLa cells. Cells were grown in 
30-mm diam. dishes containing 2ml E4 medium with 
10% calf serum. One series of dishes was treated with 
SOIU/ml HuIFN-(r (Ly) 18 h before the infection with 
poliovirus (20 PFU/cell). After 1 h at 37°C the virus was 
removed and 1 ml E4 medium containing 2% calf serum 
was added. At the indicated times medium was removed 
and cells were pulsed for 1 h as in section 2: (0) control 
cells; (0) interferon-treated cells. 
after poliovirus infection, and translated in a rab- 
bit reticulocyte lysate. The mRNAs from polio- 
virus-infected cells that were not treated with IFN 
direct the synthesis of cellular and viral proteins in 
vitro. This demonstrates that active cellular 
mRNAs can be detected after infection and sug- 
gests that such mRNA is not degraded. It also 
demonstrates that viral RNA is present and can be 
detected. This is in agreement with other reports 
obtained using picornavirus-infected cells [24,25]. 
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Fig.2. Stability of the total cellular RNA in interferon- 
treated poliovirus-infected HeLa cells. Cells were grown 
in lOO-mm diam. dishes containing 10ml E4 medium 
with 10% calf serum and labelled with [3zP]phosphate as 
in section 2. The labelled RNA was extracted 5 h after in- 
fection: (a) uninfected untreated cells; (b) uninfected 
IFN-treated cells; (c) poliovirus-infected untreated cells; 
(d) poliovirus-infected IFN-treated cells. 
The mRNAs extracted from IFN-treated cells 
after poliovirus infection direct the synthesis ex- 
clusively of cellular proteins (fig.3). This suggests 
that the cellular mRNAs remain active in cell-free 
protein synthesis, when maximal shut-off of cellu- 
lar protein synthesis has occurred in vivo, and this 
indicates that extensive degradation of cellular 
mRNA has not taken place. Because no poliovirus 
RNA-directed proteins are detected, this experi- 
ment also suggests that the block to poliovirus 
replication that occurs in HeLa cells treated with 
HuIFN-cu (Ly) leads to an inhibition of viral RNA 
production. Such a conclusion contrasts with the 
results in [23], where it was found that some men- 
govirus RNA can be extracted and translated in 
vitro from IFN-treated mouse L cells infected with 
mengovirus . 
Our results show that although viral and cellular 
protein synthesis is drastically blocked in inter- 
feron-treated cells after poliovirus infection, active 
cellular RNA can still be detected by cell-free 
translation. This argues that degradation of cellu- 
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Fig.3. In vitro translation of mRNAs extracted from interferon-treated poliovirus-infected HeLa cells, Total cellular 
RNA of 8 x lOa cells was extracted and in vitro translated as in section 2 from either control untreated, or poliovirus- 
infected, or IFN-treated (200 IU/ml) and poliovirus-infected cells 5 h post-infection with 20 PFU/celi. Incorporation 
with O.Sbg RNA after substraction of background was: control 110 805 cpm; poliovirus-infects 71098 cpm; 
IFN-treated poliovirus-infected 90456 cpm; incorporation without RNA, 18 553 cpm. 
lar RNA is not involved in the inhibition of protein 
synthesis. Other evidence obtained using intact 
cells showed that there is no correlation between 
the levels of 2’-5’ A synthetase and the antiviral ef- 
fect of interferon [26-281. Besides, there is now 
firm evidence indicating that 2’-S-oligo(A) is pre- 
sent in interferon-treated virus-infected cells [21]. 
In addition, authors in [30] have suggested on the 
basis of in vitro experiments that a selective degra- 
dation of viral mRNAs mediated by the 2’-S A 
system could occur in the intact cell. The possi- 
bility still remains open that such a selective degra- 
dation of viral mRNA is responsible for the anti- 
viral effects of interferon. 
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